Table III.
Fourteen pathways identified based on KEGG.
| Pathway | Count | P-value | Genes |
|---|---|---|---|
| B cell receptor signaling pathway | 6 | 0.003988 | CARD11, CD19, CR2, PLCG2, CD22, CD79A |
| Hormone synthesis | 5 | 0.022133 | TG, ADCY1, CREB3L4, PRKCB, IYD |
| Oxytocin signaling pathway | 7 | 0.034094 | ADCY1, PLA2G4A, RGS2, RYR3, CACNG4, PRKAA2, PRKCB |
| Hematopoietic cell lineage | 5 | 0.041129 | CD19, CR2, CD3E, MS4A1, CD22 |
| Platelet activation | 6 | 0.049048 | ADCY1, PLA2G4A, FGA, RASGRP1, PLCG2, RASGRP2 |
| Non-small cell lung cancer | 4 | 0.054172 | ERBB2, PLCG2, RARB, PRKCB |
| Calcium signaling pathway | 7 | 0.056584 | ADCY1, CHRM3, ERBB2, RYR3, PLCG2, CACNA1H, PRKCB |
| Wnt signaling pathway | 6 | 0.060444 | TCF7, DKK1, SFRP1, WIF1, FZD7, PRKCB |
| Inflammatory mediator regulation of TRP channels | 5 | 0.063253 | ADCY1, PLA2G4A, P2RY2, PLCG2, PRKCB |
| Melanogenesis | 5 | 0.067119 | ADCY1, TCF7, CREB3L4, FZD7, PRKCB |
| Circadian rhythm | 3 | 0.081308 | RORC, PRKAA2, BHLHE41 |
| Primary immunodeficiency | 3 | 0.095274 | CD19, CD3E, CD79A |
| MAPK signaling pathway | 8 | 0.096136 | DUSP4, PLA2G4A, RASGRP1, RASGRP2, DUSP10, CACNG4, CACNA1H, PRKCB |